Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06047457` - A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults	Phase 3
Completed	`NCT02569853` - DFN-11 Injection in Episodic Migraine With or Without Aura	Phase 3
Completed	`NCT00719134` - The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache	Phase 4
Completed	`NCT03700320` - Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine	Phase 3
Terminated	`NCT04936061` - Transnasal Cooling for Migraine	N/A
Recruiting	`NCT05281770` - Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study
Recruiting	`NCT05042037` - Probiotics as Adjunctive Migraine Prophylaxis	N/A
Recruiting	`NCT04628429` - CGRP Inhibition, Autonomic Function, and Migraine
Active, not recruiting	`NCT05028569` - Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine	Phase 3
Withdrawn	`NCT01257893` - Aspirin Resistance in Women With Migraine	N/A
Recruiting	`NCT06051604` - Mi-Helper Transnasal Cooling for Acute Treatment of Migraine	N/A
Completed	`NCT03132233` - Energy for the Brain	N/A
Completed	`NCT03939312` - Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine	Phase 3
Completed	`NCT03927144` - Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients	Phase 4
Recruiting	`NCT06248671` - Prophylactic Treatment With Atorvastatin for Episodic Migraine.	Phase 2
Recruiting	`NCT05711394` - A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine	Phase 3
Recruiting	`NCT05449145` - The Effects of Vitamin D Plus Omega-3 Polyunsaturated Fatty Acids in Patients With Episodic Migraine	N/A
Completed	`NCT04031781` - The Role of Left Prefrontal Transcranial Magnetic Stimulation in Episodic Migraine Prophylaxis	N/A
Completed	`NCT05264129` - Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine	Phase 4
Completed	`NCT04740827` - Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.	Phase 3

NCT number	NCT04166045
Study type	Interventional
Source	Theranova, L.L.C.
Contact
Status	Completed
Phase	N/A
Start date	June 12, 2020
Completion date	April 29, 2021

Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms